THIRD HARMONIC BIO INC. - COMMON STOCK

Third Harmonic Bio to Participate in Upcoming Investor Conferences in November

07 ноя 2024 15:00:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

07 ноя 2024 07:10:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences in September

10 сен 2024 15:00:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences

26 авг 2024 15:00:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

08 авг 2024 07:05:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference

28 май 2024 15:05:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

15 май 2024 07:05:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors

28 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

26 мар 2024 07:05:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference

26 фев 2024 15:00:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update

04 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2023 Financial Results

09 ноя 2023 07:30:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces Leadership Changes

31 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference

31 авг 2023 07:30:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces Second Quarter 2023 Financial Results

10 авг 2023 07:10:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335

25 июл 2023 07:30:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces First Quarter 2023 Financial Results

11 май 2023 16:00:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results

29 мар 2023 07:05:00 Источник Nasdaq GlobeNewswire

Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria

15 дек 2022 06:00:01 Источник Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference

21 ноя 2022 15:05:00 Источник Nasdaq GlobeNewswire